가시오가피 추출물 함유 조성물
    21.
    发明公开
    가시오가피 추출물 함유 조성물 有权
    含有ACANTHOPANAX SENTICOSUS的提取物的组合物

    公开(公告)号:KR1020110017660A

    公开(公告)日:2011-02-22

    申请号:KR1020090075242

    申请日:2009-08-14

    CPC classification number: A61K8/97 A23L33/105 A61K36/254 A61Q19/02 Y10S514/859

    Abstract: PURPOSE: A composition containing Acanthopanax senticosus extract is provided to suppress pigmentation by acne and to be sued in cosmetic product or medical field. CONSTITUTION: A composition for suppressing pigmentation by acne contains Acanthopanax senticosus extract as an active ingredient. The Acanthopanax senticosus extract is isolated using distilled water and C1-C5 organic solvent of hydrous or anhydrous low alcohol. An external use composition contains the composition for suppressing acne. The conten of the Acanthopanax senticosus extract is contained 0.5-20 weight% based on total weight. The external use skin composition is a cosmetic formulation.

    Abstract translation: 目的:提供含有刺五加提取物的组合物,以抑制痤疮的色素沉着,并在化妆品或医疗领域起诉。 构成:抑制痤疮色素沉着的组合物含有刺五加提取物作为活性成分。 使用蒸馏水和含水或无水低醇的C1-C5有机溶剂分离刺五加提取物。 外用组合物含有抑制痤疮的组合物。 刺五加提取物的含量为0.5-20重量%,基于总重量。 外用皮肤组合物是化妆品制剂。

    대황 추출물 함유 조성물
    22.
    发明公开
    대황 추출물 함유 조성물 无效
    含有RHUBARB萃取物的组合物

    公开(公告)号:KR1020110017645A

    公开(公告)日:2011-02-22

    申请号:KR1020090075219

    申请日:2009-08-14

    Abstract: PURPOSE: A composition containing Rheum undulatum extract is provided to suppress pigmentation due to acne and to be used in a cosmetic field or medical field. CONSTITUTION: A composition for suppressing pigmentation due to acne contains Rheum undulatum extract as an active ingredient. An external use skin composition contains the composition for suppressing pigmentation. The content of the Rheum undulatum extract is 0.5-20 weight%. The composition is a cosmetic formulation. An aftercare composition for acne contains Rheum undulatum extract as an active ingredient.

    Abstract translation: 目的:提供含有大黄精华提取物的组合物以抑制由于痤疮引起的色素沉着并用于化妆品领域或医疗领域。 构成:用于抑制由于痤疮引起的色素沉着的组合物含有作为有效成分的无色杜鹃花提取物。 外用皮肤组合物含有抑制色素沉着的组合物。 大黄精华提取物的含量为0.5〜20重量%。 组合物是化妆品制剂。 用于痤疮的保健用组合物含有作为活性成分的大黄精华提取物。

    장미 추출물 함유 조성물
    23.
    发明公开
    장미 추출물 함유 조성물 无效
    含有玫瑰提取物的组合物

    公开(公告)号:KR1020110017566A

    公开(公告)日:2011-02-22

    申请号:KR1020090075085

    申请日:2009-08-14

    Abstract: PURPOSE: A composition containing Rosa spp. extract is provided to suppress pigmentation by acne and to be used in food or cosmetic field. CONSTITUTION: A composition for suppressing pigmentation by acne contains 0.5-20 weight% of Rosa spp. extract as an active ingredient. An external use skin composition contains the composition for suppressing pigmentation. The composition is a cosmetic formulation. A food additive or health food composition contains the composition for suppressing pigmentation or aftercare composition.

    Abstract translation: 目的:含有罗莎属的组合物。 提取物以抑制痤疮的色素沉着,并用于食品或化妆品领域。 构成:用于抑制痤疮色素沉着的组合物含有0.5-20重量%的罗莎属。 提取物作为活性成分。 外用皮肤组合物含有抑制色素沉着的组合物。 组合物是化妆品制剂。 食品添加剂或保健食品组合物含有抑制色素沉着或后处理组合物的组合物。

    황기 추출물 함유 조성물
    24.
    发明公开
    황기 추출물 함유 조성물 无效
    含有ASTRAGALUS膜的提取物的组合物

    公开(公告)号:KR1020110017563A

    公开(公告)日:2011-02-22

    申请号:KR1020090075082

    申请日:2009-08-14

    Abstract: PURPOSE: A composition containing Astraglus membranaceus extract is provided to prevent acne pigmentation and/or scar and to be used in cosmetic, food, or medial field. CONSTITUTION: A composition for suppressing acne pigmentation contains Astraglus membranaceus extract as an active ingredient. The Astraglus membranaceus extract suppresses gelatinase. The composition is used in the form of cosmetic product. A composition for aftercare of acne contains Astraglus membranaceus extract as an active ingredient. A food additive or health food contains Astraglus membranaceus extract.

    Abstract translation: 目的:提供含有黄芪提取物的组合物,以防止痤疮色素沉着和/或疤痕,并用于化妆品,食品或内部领域。 构成:抑制痤疮色素沉着的组合物含有黄芪提取物作为活性成分。 黄芪提取物抑制明胶酶。 该组合物以化妆品的形式使用。 用于治疗痤疮的组合物含有黄芪提取物作为活性成分。 食品添加剂或保健食品含有黄芪提取物。

    염증 억제능을 갖는 녹차 산성 다당체 및 이를 함유하는 항염 조성물
    25.
    发明公开
    염증 억제능을 갖는 녹차 산성 다당체 및 이를 함유하는 항염 조성물 无效
    具有抗炎活性的绿茶的酸性多糖和含有其的抗炎组合物

    公开(公告)号:KR1020100026835A

    公开(公告)日:2010-03-10

    申请号:KR1020080085990

    申请日:2008-09-01

    Abstract: PURPOSE: An anti-inflammatory composition containing acid polysaccharide of green tea is provided to relieve skin irritation, pruritus, and inflammation and to treat and prevent inflammatory dermatitis. CONSTITUTION: An acid polysaccharide having a function of suppressing inflammation is isolated from green tea. The acid polysaccharide is isolated by extracting with hot water and performing ultrafiltration and ethanol precipitation. The acid polysaccharide is rhamnose, arabinose, ribose, xylose, glucose, mannose and D-galactose. A pharmaceutical composition for preventing or treating inflammatory dermatitis contains 0.05-50 weight% of acid polysaccharide as an active ingredient. A cosmetic composition having function of suppressing inflammation contains 0.05-5 weight% of acid polysaccharide based on total weight. The cosmetic composition is used in the form of skin softener, nutrition lotion, massage cream, moisture cream, nutrition cream, pack, gel, body lotion, body cream, body oil, shampoo, and body cleanser.

    Abstract translation: 目的:提供含有绿茶酸多糖的抗炎组合物,以缓解皮肤刺激,瘙痒和炎症,并治疗和预防炎症性皮炎。 构成:从绿茶中分离具有抑制炎症功能的酸性多糖。 酸性多糖用热水提取分离,进行超滤和乙醇沉淀。 酸多糖是鼠李糖,阿拉伯糖,核糖,木糖,葡萄糖,甘露糖和D-半乳糖。 用于预防或治疗炎性皮炎的药物组合物含有0.05-50重量%的酸性多糖作为活性成分。 具有抑制炎症功能的化妆品组合物含有0.05-5重量%的基于总重量的酸性多糖。 化妆品组合物以皮肤柔软剂,营养乳液,按摩霜,防湿霜,营养霜,包装,凝胶,身体乳液,身体霜,人体油,洗发剂和身体清洁剂的形式使用。

    유사지질 복합체 및 이를 함유하는 피부 외용제 조성물
    26.
    发明公开
    유사지질 복합체 및 이를 함유하는 피부 외용제 조성물 有权
    PSEUDOLIPID复合混合物和含有其的皮肤外用应用组合物

    公开(公告)号:KR1020100007169A

    公开(公告)日:2010-01-22

    申请号:KR1020080067676

    申请日:2008-07-11

    CPC classification number: A61K8/68 A61K8/361 A61K8/63 A61Q19/007

    Abstract: PURPOSE: A skin external composition containing pseudoceramide complex including pseudoceramide and stearic acid is provided to ensure high moisture dipping ability and skin moisturization effect. CONSTITUTION: A pseudoceramide complex contains 10-90 weight% of pseudoceramide and stearic acid based on total weight. The complex further contains 0.0001-30 weight% of cholesterol. The pseudoceramide is denoted by one selected from chemical formulas 1 to 6. The weight ratio of pseudoceramide and stearic acid is 1:1, and pseudoceramide and cholesterol is 1:0.5. The skin external composition contains 0.01-40 weight% of the pseudoceramide complex. The composition is cosmetic composition or pharmaceutical composition.

    Abstract translation: 目的:提供含有假花生酰胺复合物的皮肤外用组合物,包括假花生酰胺和硬脂酸,以确保高水分浸渍能力和皮肤保湿效果。 构成:假甲酰胺复合物含有10-90%(重量)的假花生酰胺和硬脂酸。 该复合物还含有0.0001-30重量%的胆固醇。 假花生酰胺由选自化学式1至6的一个表示。假花生酰胺和硬脂酸的重量比为1:1,假花生酰胺和胆固醇为1:0.5。 皮肤外用组合物含有0.01-40重量%的伪心肌酰胺复合物。 组合物是化妆品组合物或药物组合物。

    항균성 펩티드의 발현을 회복시키기 위한 스핑고실포스포릴콜린 길항제의 용도
    27.
    发明公开
    항균성 펩티드의 발현을 회복시키기 위한 스핑고실포스포릴콜린 길항제의 용도 有权
    用于恢复抗微生物肽表达的SPHINGOSYLPHOSPHORLCHOLINE ANTAGONIST的使用

    公开(公告)号:KR1020090016595A

    公开(公告)日:2009-02-16

    申请号:KR1020087030865

    申请日:2006-12-08

    Abstract: A sphingosylphosphorylcholine(SPC) antagonist is provided to prevent and treat diseases related to the expression decrease of anti-bacterial peptide such as atopic dermatitis, and screen the SPC antagonist by analyzing the expression recover of gene or protein of the anti-bacterial peptide. The sphingosylphosphorylcholine(SPC) antagonist manufactures the medicine for restoring the expression of anti-bacterial peptide back to the normal level in mammal requiring the expression restoration of anti-bacterial peptide. The screening method of the sphingosylphosphorylcholine(SPC) antagonist comprises the steps of: treating the object with sphingosylphosphorylcholine or its derivative to inhibit expression of anti-bacterial peptide; and treating the object with the SPC antagonist candidate material, and analyzing the expression restoration level of the anti-bacterial peptide in the object.

    Abstract translation: 提供鞘糖基磷酰胆碱(SPC)拮抗剂以预防和治疗与抗细菌肽如特应性皮炎的表达降低相关的疾病,并通过分析抗细菌肽的基因或蛋白质的表达恢复来筛选SPC拮抗剂。 鞘氨醇磷酰胆碱(SPC)拮抗剂在需要抗菌肽表达恢复的哺乳动物中制备了将抗菌肽的表达恢复至正常水平的药物。 鞘氨醇磷酰胆碱(SPC)拮抗剂的筛选方法包括以下步骤:用鞘糖基磷酰胆碱或其衍生物处理物体以抑制抗菌肽的表达; 并用SPC拮抗剂候选物质处理对象,分析对象中抗菌肽的表达恢复水平。

Patent Agency Ranking